Skip to content
Search

Latest Stories

Pharmacists to be allowed to issue 'fit notes' in bid to ease burden on GPs

In a bid to ease 'fit notes' burden on GPs, pharmacists and other healthcare professionals in England, Wales and Scotland will be allowed to sign people off work under new laws which come into effect on July 1.

However, it's unclear if the new measure includes community pharmacists or it it's restricted to pharmacists working in general practice. Pharmacy Business is waiting for clarification from the Department of Health and Social Care.


Responding to news, RPS president Claire Anderson said: “Pharmacists are taking on increasingly clinical roles, and the provision of a fit note may be an appropriate part of a consultation with a patient. However, we have a number of concerns that must be addressed to enable pharmacists to provide fit notes.

“First, although pharmacists working in general practices have access to medical records, this is not the case for community pharmacists: it is essential that this is changed to ensure pharmacists have access to all the information required to be able to safely issue a fit note.

“Second, pharmacists already have a significant workload so additional roles must be properly planned for and funded services developed.

“Finally, it is essential that the public is given clear information about where fit notes can be obtained from and not misled that they can be provided by all pharmacists.”

Employers ask people who are off work for more than seven consecutive days to produce fitness notes from a healthcare professional which now can be issued by pharmacists, nurses, physiotherapists and occupational therapists, in addition to GPs.

These notes state whether a patient is 'unfit for work' or 'may be fit for work' with some workplace adjustments.

Health secretary Sajid Javid said: "I know how important it is for people to be able to see their GP speedily and in the way they want.

"That's why we are slashing bureaucracy to reduce GPs workloads, so they can focus on seeing patients and giving people the care they urgently need.

"It is part of our mission to deliver an extra 50 million GP appointments a year by 2024."

Pharmacy minister Maria Caulfield said the move was "another step towards helping to deliver an extra 50million appointments in general practice a year by 2024."

More For You

Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less